Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase
Zhang, Jie1; Liu, Hongchuan1; Zhu, Kongkai2; Gong, Shouzhe1; Dramsi, Shaynoor3,4; Wang, Ya-Ting3; Li, Jiafei1; Chen, Feifei1; Zhang, Ruihan2; Zhou, Lu5
刊名PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
2014-09-16
卷号111期号:37页码:13517-13522
关键词nosocomial infection LPXTG motif antivirulence computational screening
ISSN号0027-8424
DOI10.1073/pnas.1408601111
文献子类Article
英文摘要Methicillin-resistant Staphylococcus aureus (MRSA) is the most frequent cause of hospital-acquired infection, which manifests as surgical site infections, bacteremia, and sepsis. Due to drug-resistance, prophylaxis of MRSA infection with antibiotics frequently fails or incites nosocomial diseases such as Clostridium difficile infection. Sortase A is a transpeptidase that anchors surface proteins in the envelope of S. aureus, and sortase mutants are unable to cause bacteremia or sepsis in mice. Here we used virtual screening and optimization of inhibitor structure to identify 3-(4-pyridinyl)-6-(2-sodiumsulfonatephenyl)[1,2,4] triazolo[3,4-b][1,3,4] thiadiazole and related compounds, which block sortase activity in vitro and in vivo. Sortase inhibitors do not affect in vitro staphylococcal growth yet protect mice against lethal S. aureus bacteremia. Thus, sortase inhibitors may be useful as antiinfective therapy to prevent hospital-acquired S. aureus infection in high-risk patients without the side effects of antibiotics.
资助项目National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant[2013ZX09507-004] ; National Natural Science Foundation of China[91313303] ; National Natural Science Foundation of China[20972173] ; National Natural Science Foundation of China[81230076] ; Hi-Tech Research and Development Program of China[2012AA020302] ; Hi-Tech Research and Development Program of China[2012AA020301] ; National Institute of Allergy and Infectious Diseases[AI038897] ; Computer Network Information Center[00000000] ; Chinese Academy of Sciences[00000000] ; Shanghai Supercomputing Center[00000000]
WOS关键词GRAM-POSITIVE BACTERIA ; CELL-WALL ; SURFACE-PROTEINS ; ACTIVE-SITE ; ENTEROCOCCUS-FAECALIS ; CLOSTRIDIUM-DIFFICILE ; SUBSTRATE COMPLEX ; UNITED-STATES ; A INHIBITORS ; VIRULENCE
WOS研究方向Science & Technology - Other Topics
语种英语
出版者NATL ACAD SCIENCES
WOS记录号WOS:000341630000065
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/276899]  
专题药物发现与设计中心
中科院受体结构与功能重点实验室
新药研究国家重点实验室
药理学第三研究室
药理学第一研究室
通讯作者Schneewind, Olaf
作者单位1.Chinese Acad Sci, Dept Mol Pharmacol, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China;
3.Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA;
4.Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, CNRS, Equipe Rech Labellisee 3526, F-75724 Paris, France;
5.Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Jie,Liu, Hongchuan,Zhu, Kongkai,et al. Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,2014,111(37):13517-13522.
APA Zhang, Jie.,Liu, Hongchuan.,Zhu, Kongkai.,Gong, Shouzhe.,Dramsi, Shaynoor.,...&Yang, Cai-Guang.(2014).Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,111(37),13517-13522.
MLA Zhang, Jie,et al."Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase".PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 111.37(2014):13517-13522.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace